Medtronic (NYSE:MDT) said today it won FDA premarket approval for its app-based MyCareLink Smart Monitor remote monitoring system for patients with implanted pacemakers. The Fridley, Minn.-based medical giant said the newly-cleared monitoring system is the world’s 1st app-based pacemaker remote monitor. The system allows patients to transmit data from their Medtronic pacers to physicians who can […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
ACIST launches FFR trial
Interventional and diagnostic tech company ACIST said today it enrolled the 1st patient in a study of catheter-based interrogation and standard fractional flow reserve measurement. The study, slated to enroll 240 patients, is intended to investigate the measurement accuracy and incident of drift and device success using ACIST’s Navvus Rapid Exchange FFR microcatheter. “As with […]
Medtronic, Hansen to present clinical trial data at VEITHSymposium
Medtronic (NYSE:MDT) and Hansen Medical (NSDQ:HNSN) said they are slated to present new clinical information at this year’s annual VEITHSymposium in New York City. Medtronic said today it plans to present 4-year subset data results from the ENGAGE global registry study of its Endurant AAA stent graft system. The trial analyzed patients with hostile neck anatomies treated with […]
AUM Cardiovascular finishes pivotal trial enrollment
AUM Cardiovascular said last week it completed enrollment for the pivotal study of its CADence handheld heart disease diagnostics device. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company’s site. The company’s name is based on a […]
LoneStar Heart touts 1-year Algisyl data
LoneStar Heart yesterday presented 1-year data from a follow-up study of its Algisyl hydrogel cardiac implant designed to treat patients with failing heart muscle. The presentation was made at the American Heart Association’s annual meeting in Orlando and published in the European Journal of Heart Failure. Algisyl is a novel inert hydrogel that is designed to be […]
Boston Scientific dips on Medicare reimbursement hit for Watchman anti-stroke device
Boston Scientific (NYSE:BSX) shares took a hit yesterday after a Centers for Medicare & Medicaid Services proposal that would limit coverage for the Watchman anti-stroke device. Investors also likely reacted to a pair of Class II recalls from the FDA, sending BSX shares down -4.2% to $18.01 apiece yesterday. Watchman, a transcatheter implant designed to seal off […]
Boston Scientific touts Watchman study data
Boston Scientific (NYSE:BSX) yesterday presented data on its Watchman left atrial appendage occlusion device. The data was presented at the annual American Heart Association’s Scientific Sessions in Orlando, Fla. The data comes from the Ewolution registry, the 1st real-world study of the Marlborough, Mass.-based company’s Watchman device. The patient population of the study was the ‘highest […]
Xeltis completes 2nd feasibility trial of cardiac valve system
Xeltis said today it completed its 2nd feasibility trial of its bioabsorbable regenerative heart valve technology designed to allow endogenous tissue restoration. The Swiss med tech firm is designing valves and vessels out of polymers structured as a “porous matrix” designed to be absorbed and leave the patient with its own healthy tissue, the company […]
Study shows advantages of mitral valve replacement over repair
(Reuters) — Patients with severe leakage from the mitral valve of the heart who had the valve replaced had significantly lower rates of recurrence and heart failure two years after the procedure than those who underwent surgical repair, according to data presented on Monday. Mitral valve regurgitation, in which blood leaks backward through the valve […]
Glaukos touts 3-year data from iStent trial
Glaukos (NYSE:GKOS) today released data from a 3-year study of its iStent travecular micro-bypass stent, touting sustained reductions in intra-ocular pressure after treatment with 2 of the devices. The study was published in the November issue of the Clinical Ophtalmology journal, the company said. The iStent trabecular micro-bypass stent is a tiny titanium stent designed to […]
Medtronic’s Micra pacer trial meets endpoints
Medtronic‘s (NYSE:MDT) entry into the micro-sized leadless pacemaker market has met its primary safety and effectiveness endpoints with “wide margins,” the company said today. The Micra transcatheter pacing system, which at 1/10th the size of a conventional pacemaker is roughly the size of a large vitamin, is designed to be implanted via catheter in the […]